SEC Form 4 · accession 0001209191-16-155999
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey W Sherman
Officer — EVP and Chief Medical Officer
Period of report
Dec 16, 2016
Accepted (ET)
Dec 19, 2016 · 6:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Dec 16, 2016 | M | 8,500 | $2.40 | A | 167,750 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.40 | Dec 16, 2016 | M | 8,500 | D | — | Jan 1, 2023 | Ordinary Shares | 8,500 | 5,313 | D |
Explanation of responses
- F1The stock option vests in 48 equal monthly installments following January 2, 2013, the date of grant.